European research networks to facilitate drug research in children
暂无分享,去创建一个
C. Giaquinto | D. Bonifazi | A. Ceci | M. Turner | S. D. de Wildt | B. Nafria | P. Rossi | J. Claverol | S. Attar | Katharine Cheng | Heidrun Hildebrand
[1] K. Norga,et al. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. , 2020, European journal of cancer.
[2] Annalisa Landi,et al. Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe‐wide trials , 2020, Acta paediatrica.
[3] B. Nafria,et al. Children’s views on taking medicines and participating in clinical trials , 2019, Archives of Disease in Childhood.
[4] B. Phillips,et al. Framework to help design and review research involving children , 2019, Archives of Disease in Childhood.
[5] C. Tuleu,et al. EPTRI – European Paediatric Translational Research Infrastructure. Bridging the gaps of the paediatric excellence medicine , 2019, British Journal of Pharmacy.
[6] B. Phillips,et al. How to involve children and young people in what is, after all, their research , 2019, Archives of Disease in Childhood.
[7] B. Phillips,et al. Making research central to good paediatric practice , 2019, Archives of Disease in Childhood.
[8] G. Kearns,et al. Developmental Changes in Pharmacokinetics and Pharmacodynamics , 2018, Journal of clinical pharmacology.
[9] A. Saint‐Raymond,et al. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation , 2017, Pediatric Drugs.
[10] Catriona Manville,et al. The National Institute for Health Research at 10 Years: An Impact Synthesis: 100 Impact Case Studies. , 2016, Rand health quarterly.
[11] B. Carleton,et al. Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine , 2016, Pediatric Drugs.
[12] L. Dimeglio,et al. Special article: 2014 Pediatric Clinical Trials Forum , 2016, Pediatric Research.
[13] C. Giaquinto,et al. Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines , 2014, European Journal of Pediatrics.
[14] J. Karres,et al. Juvenile animal studies and pediatric drug development: a European regulatory perspective. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.
[15] E. Napoleone. Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency) , 2011, Italian journal of pediatrics.
[16] 崎山美知代. 有効性に関するトピックの動向 ICH E11‐Addendum(R1):Clinical Investigation of Medicinal Products in the Pediatric Population Lisbon2016EWG会議の報告 , 2017 .
[17] M. Schrappe,et al. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer. , 2015, European journal of cancer.
[18] Ritu Sadana,et al. Knowledge for better health: a conceptual framework and foundation for health research systems. , 2003, Bulletin of the World Health Organization.